Safety and feasibility of high-pressure transvenous limb perfusion with 0.9% saline in human muscular dystrophy

Molecular Therapy

Volumn 20, Issue 2, 2012, Pages 456-461

  Fan, Zheng ^a   Kocis, Keith ^a   Valley, Robert ^a   Howard, James F ^a   Chopra, Manisha ^a   An, Hongyu ^a   Lin, Weili ^a   Muenzer, Joseph ^a   Powers, William ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD VESSEL INJURY; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; GENE TARGETING; GENE THERAPY; HIGH PRESSURE TRANSVENOUS LIMB PERFUSION; HUMAN; INTRAVENOUS ANESTHESIA; INTRAVENOUS CATHETER; KIDNEY FUNCTION; LIMB PERFUSION; MALE; MUSCLE FUNCTION; MUSCULAR DYSTROPHY; NERVE FUNCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIMETRY; SAFETY; SAPHENOUS VEIN;

EID: 84856510252     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2011.137     Document Type: Article

References (29)

1. Mendell, JR, Moxley, RT, Griggs, RC, Brooke, MH, Fenichel, GM, Miller, JP et al. (1989). Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy. N Engl J Med 320: 1592-1597. (Pubitemid 19154573)
2. Kay, MA, Manno, CS, Ragni, MV, Larson, PJ, Couto, LB, McClelland, A et al. (2000). Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector. Nat Genet 24: 257-261. (Pubitemid 30132193)
3. Mendell, JR, Rodino-Klapac, LR, Rosales-Quintero, X, Kota, J, Coley, BD, Galloway, G et al. (2009). Limb-girdle muscular dystrophy type 2D gene therapy restores alphasarcoglycan and associated proteins. Ann Neurol 66: 290-297.
4. Stedman, H, Wilson, JM, Finke, R, Kleckner, AL and Mendell, J (2000). Phase I clinical trial utilizing gene therapy for limb girdle muscular dystrophy: alpha-, beta-, gamma-, or delta-sarcoglycan gene delivered with intramuscular instillations of adenoassociated vectors. Hum Gene Ther 11: 777-790. (Pubitemid 30180282)
5. Hagstrom, JE, Hegge, J, Zhang, G, Noble, M, Budker, V, Lewis, DL et al. (2004). A facile nonviral method for delivering genes and siRNAs to skeletal muscle of mammalian limbs. Mol Ther 10: 386-398. (Pubitemid 39117883)
6. Davis, HL, Demeneix, BA, Quantin, B, Coulombe, J and Whalen, RG (1993). Plasmid DNA is superior to viral vectors for direct gene transfer into adult mouse skeletal muscle. Hum Gene Ther 4: 733-740. (Pubitemid 24305767)
7. Kessler, PD, Podsakoff, GM, Chen, X, McQuiston, SA, Colosi, PC, Matelis, LA et al. (1996). Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein. Proc Natl Acad Sci USA 93: 14082-14087. (Pubitemid 26424249)
8. Ragot, T, Vincent, N, Chafey, P, Vigne, E, Gilgenkrantz, H, Couton, D et al. (1993). Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice. Nature 361: 647-650. (Pubitemid 23062399)
9. Kamimura, K, Zhang, G and Liu, D (2010). Image-guided, intravascular hydrodynamic gene delivery to skeletal muscle in pigs. Mol Ther 18: 93-100.
10. Pichavant, C, Chapdelaine, P, Cerri, DG, Dominique, JC, Quenneville, SP, Skuk, D et al. (2010). Expression of dog microdystrophin in mouse and dog muscles by gene therapy. Mol Ther 18: 1002-1009.
11. Wang, B, Li, J, Qiao, C, Chen, C, Hu, P, Zhu, X et al. (2008). A canine minidystrophin is functional and therapeutic in mdx mice. Gene Ther 15: 1099-1106. (Pubitemid 352006080)
12. Florence, JM, Fox, PT, Planer, GJ and Brooke, MH (1985). Activity, creatine kinase, and myoglobin in Duchenne muscular dystrophy: a clue to etiology? Neurology 35: 758-761. (Pubitemid 15067040)
13. Jackson, MJ, Round, JM, Newham, DJ and Edwards, RH (1987). An examination of some factors influencing creatine kinase in the blood of patients with muscular dystrophy. Muscle Nerve 10: 15-21. (Pubitemid 17223305)
14. Bromberg, MB and Spiegelberg, T (1997). The influence of active electrode placement on CMAP amplitude. Electroencephalogr Clin Neurophysiol 105: 385-389. (Pubitemid 27446027)
15. Kong, X, Lesser, EA and Gozani, SN (2009). Repeatability of nerve conduction measurements derived entirely by computer methods. Biomed Eng Online 8: 33.
16. Hegge, JO, Wooddell, CI, Zhang, G, Hagstrom, JE, Braun, S, Huss, T et al. (2010). Evaluation of hydrodynamic limb vein injections in nonhuman primates. Hum Gene Ther 21: 829-842.
17. Barry, LA, Balliana, BS, Galeppi AC. Intravenous regional anesthesia (Bier block). Techniques in Regional Anesthesia and Pain Management, Volume 10, Issue 3, 2006, pp 123-131. (Pubitemid 44557117)
18. Vigen, KK, Hegge, JO, Zhang, G, Mukherjee, R, Braun, S, Grist, TM et al. (2007). Magnetic resonance imaging-monitored plasmid DNA delivery in primate limb muscle. Hum Gene Ther 18: 257-268. (Pubitemid 46626464)
19. Kornegay, JN, Li, J, Bogan, JR, Bogan, DJ, Chen, C, Zheng, H et al. (2010). Widespread muscle expression of an AAV9 human mini-dystrophin vector after intravenous injection in neonatal dystrophin-deficient dogs. Mol Ther 18: 1501-1508.
20. Qiao, C, Li, J, Zheng, H, Bogan, J, Li, J, Yuan, Z et al. (2009). Hydrodynamic limb vein injection of adeno-associated virus serotype 8 vector carrying canine myostatin propeptide gene into normal dogs enhances muscle growth. Hum Gene Ther 20: 1-10.
21. Rodino-Klapac, LR, Montgomery, CL, Mendell, JR and Chicoine, LG (2011). AAVmediated gene therapy to the isolated limb in rhesus macaques. Methods Mol Biol 709: 287-298.
22. Petrov, M, Malik, A, Mead, A, Bridges, CR and Stedman, HH (2011). Gene transfer to muscle from the isolated regional circulation. Methods Mol Biol 709: 277-286.
23. Plante, GE, Chakir, M, Ettaouil, K, Lehoux, S and Sirois, P (1996). Consequences of alteration in capillary permeability. Can J Physiol Pharmacol 74: 824-833. (Pubitemid 26426572)
24. Labropoulos, N, Tiongson, J, Pryor, L, Tassiopoulos, AK, Kang, SS, Ashraf Mansour, M et al. (2003). Definition of venous reflux in lower-extremity veins. J Vasc Surg 38: 793-798. (Pubitemid 37254810)
25. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories (2002). ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166:111-117.
26. van den Brand, JG, Nelson, T, Verleisdonk, EJ and van der Werken, C (2005). The diagnostic value of intracompartmental pressure measurement, magnetic resonance imaging, and near-infrared spectroscopy in chronic exertional compartment syndrome: a prospective study in 50 patients. Am J Sports Med 33: 699-704. (Pubitemid 40593766)
27. Marsch, SC, Sluga, M, Studer, W, Barandun, J, Scharplatz, D and Ummenhofer, W (2004). 0.5% versus 1.0% 2-chloroprocaine for intravenous regional anesthesia: a prospective, randomized, double-blind trial. Anesth Analg 98: 1789-93, table of contents. (Pubitemid 38668935)
28. Comunale, ME (2003). A laboratory evaluation of the level 1 rapid infuser (H1025) and the Belmont instrument fluid management system (FMS 2000) for rapid transfusion. Anesth Analg. 97:1064-1069, table of contents. (Pubitemid 37158690)
29. Yushkevich, PA, Piven, J, Hazlett, HC, Smith, RG, Ho, S, Gee, JC et al. (2006). User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability. Neuroimage 31: 1116-1128. (Pubitemid 43851334)